We are live on ! Find out more
TRML

Tourmaline Bio
TRML

Delisted

TRML was delisted on the 27th of October, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of TRML yet.

TRML Hedge Fund Activity: Q4 2025 in Review

0 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Tourmaline Bio (TRML) for Q4 2025, worth a combined $0 — down 100% from $1.03B a quarter earlier.

Sellers outnumbered buyers: 132 funds closed out of TRML and 0 opened new positions — a net loss of 132 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $122M sold.

  • 0 institutional investors held Tourmaline Bio (TRML) as of Q4 2025, down from 134 in Q3 2025.
  • Funds reported $0 of Tourmaline Bio stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Tourmaline Bio positions in Q4 2025 and 132 closed out, a net change of -132 holders.
  • The largest Tourmaline Bio seller in Q4 2025 was Avoro Capital Advisors, an estimated $122M sold.

Based on aggregated 13F filings for Q4 2025.